PatientsVille.com Logo

Antineoplastic Side Effects

PatientsVille

Common Antineoplastic Side Effects


The most commonly reported Antineoplastic side effects (click to view or check a box to report):

Dyspnoea (10)
Muscular Weakness (5)
Death (5)
Coordination Abnormal (5)
Confusional State (5)
Fatigue (4)
Renal Impairment (4)
Febrile Neutropenia (4)
Hyponatraemia (3)
Dehydration (3)
Mucosal Inflammation (3)
Chills (3)
Weight Decreased (3)
Nausea (3)
Therapeutic Response Decreased (3)
White Blood Cell Count Decreased (3)
Neoplasm Progression (3)
Oral Pain (2)
Peritoneal Carcinoma (2)
Pain (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Antineoplastic Side Effects Reported to FDA



Antineoplastic Side Effect Report#8472854-3
Feeling Cold
This is a report of a 57-year-old male patient (weight: NA) from United States, suffering from the following health symptoms/conditions: NA, who was treated with Antineoplastic Agents (dosage: NA, start time:
Jun 26, 2012), combined with:
  • Leukine (Unk)
and developed a serious reaction and side effect(s): Feeling Cold after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in male patients, resulting in Feeling Cold side effect.
Antineoplastic Side Effect Report#8472752-5
Injection Site Pruritus
This report suggests a potential Antineoplastic Agents Injection Site Pruritus side effect(s) that can have serious consequences. A 71-year-old male patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: NA and used Antineoplastic Agents (dosage: NA) starting NS. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Injection Site PruritusAdditional drugs used concurrently:
  • Leukine (250 ?g, Tiw)
Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Injection Site Pruritus, may still occur.
Antineoplastic Side Effect Report#8449549-5
Pneumonia
This Pneumonia problem was reported by a physician from France. A 30-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: breast cancer. On NS this consumer started treatment with Antineoplastic Agents (dosage: NA). The following drugs were being taken at the same time:
  • Neulasta
When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: PneumoniaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Pneumonia, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8436775-4
Interstitial Lung Disease, Respiratory Failure, Dyspnoea, Pyrexia
This Interstitial Lung Disease side effect was reported by a consumer or non-health professional from Japan. A 71-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Antineoplastic Agents (drug dosage: NA), which was initiated on
Dec 28, 2010. Concurrently used drugs:
  • Omeprazole
  • Rebamipide
  • Zometa
  • Maglax
  • Therapeutic Radiopharmaceuticals
  • Vitamin B12
  • Loxoprofen
  • Docetaxel (80 Mg/4 Ml)
.After starting to take Antineoplastic Agents the consumer reported adverse symptoms, such as: Interstitial Lung Disease, Respiratory Failure, Dyspnoea, PyrexiaThese side effects may potentially be related to Antineoplastic Agents.
Antineoplastic Side Effect Report#8422220-1
Hepatitis Toxic, Blood Bilirubin Increased, Jaundice, Abdominal Distension, Chromaturia, Transaminases Increased, Deficiency Of Bile Secretion
This is a report of a 62-year-old male patient (weight: NA) from Spain, suffering from the following health symptoms/conditions: NA, who was treated with Antineoplastic Agents (dosage: NA, start time:
May 02, 2012), combined with:
  • Primovist (Unk)
and developed a serious reaction and side effect(s): Hepatitis Toxic, Blood Bilirubin Increased, Jaundice, Abdominal Distension, Chromaturia, Transaminases Increased, Deficiency Of Bile Secretion after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in male patients, resulting in Hepatitis Toxic side effect.
Antineoplastic Side Effect Report#8405289-X
Neoplasm Malignant
This report suggests a potential Antineoplastic Agents Neoplasm Malignant side effect(s) that can have serious consequences. A 52-year-old male patient (weight: NA) from Brazil was diagnosed with the following symptoms/conditions: neoplasm malignant and used Antineoplastic Agents (dosage: NA) starting
Jan 01, 2012. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Neoplasm MalignantAdditional drugs used concurrently:
  • Granulokine (Unk)
Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Neoplasm Malignant, may still occur.
Antineoplastic Side Effect Report#8385152-3
Myelocytosis
This Myelocytosis problem was reported by a physician from France. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: acute lymphocytic leukaemia. On NS this consumer started treatment with Antineoplastic Agents (dosage: NA). The following drugs were being taken at the same time:
  • Neulasta
When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: MyelocytosisAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Myelocytosis, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8378770-X
Abscess
This Abscess side effect was reported by a consumer or non-health professional from Israel. A 44-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer,prophylaxis.The patient was prescribed Antineoplastic Agents (drug dosage: Unk Unk, Q3wk), which was initiated on NS. Concurrently used drugs:
  • Neulastim (Unk Unk, Q3wk)
.After starting to take Antineoplastic Agents the consumer reported adverse symptoms, such as: AbscessThese side effects may potentially be related to Antineoplastic Agents. The patient was hospitalized.
Antineoplastic Side Effect Report#8345822-X
Therapeutic Response Decreased, Mantle Cell Lymphoma
This is a report of a 72-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: mantle cell lymphoma,idiopathic thrombocytopenic purpura, who was treated with Antineoplastic Agents (dosage: Unk, start time: NS), combined with:
  • Nplate
and developed a serious reaction and side effect(s): Therapeutic Response Decreased, Mantle Cell Lymphoma after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in female patients, resulting in Therapeutic Response Decreased side effect.
Antineoplastic Side Effect Report#8276860-3
Dyspnoea, Confusional State, Coordination Abnormal, Muscular Weakness
This report suggests a potential Antineoplastic Agents Dyspnoea side effect(s) that can have serious consequences. A 68-year-old female patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: NA and used Antineoplastic Agents (dosage: NA) starting
Feb 16, 2012. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Dyspnoea, Confusional State, Coordination Abnormal, Muscular WeaknessAdditional drugs used concurrently:
  • Rifampicin
  • Rifampicin
The patient was hospitalized. Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Antineoplastic Side Effect Report#8275019-3
Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase Increased
This Decreased Appetite problem was reported by a physician from Germany. A 55-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 25, 2012 this consumer started treatment with Antineoplastic Agents (dosage: Unk). The following drugs were being taken at the same time:
  • Xgeva (120 Mg, Q4wk)
  • Ibuprofen (600 Mg, Tid)
When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase IncreasedAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Decreased Appetite, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8270027-0
Febrile Neutropenia, Infection
This Febrile Neutropenia side effect was reported by a physician from United States. A 62-year-old female patient (weight:NA) experienced the following symptoms/conditions: acute lymphocytic leukaemia.The patient was prescribed Antineoplastic Agent (no Ingredients/substances) (drug dosage: NA), which was initiated on
Dec 01, 2008. Concurrently used drugs:
  • Gleevec (600 Mg, Qd, Oral)
.After starting to take Antineoplastic Agent (no Ingredients/substances) the consumer reported adverse symptoms, such as: Febrile Neutropenia, InfectionThese side effects may potentially be related to Antineoplastic Agent (no Ingredients/substances). The patient was hospitalized.
Antineoplastic Side Effect Report#8266692-4
Arthralgia, Fractured Sacrum
This is a report of a 52-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: lung neoplasm malignant, who was treated with Antineoplastic Agents (dosage: NA, start time:
Mar 09, 2012), combined with:
  • Neulasta (6 Mg, Unk)
and developed a serious reaction and side effect(s): Arthralgia, Fractured Sacrum after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in female patients, resulting in Arthralgia side effect.
Antineoplastic Side Effect Report#8266276-8
Syncope, Dysstasia, Dizziness
This report suggests a potential Antineoplastic Agents Syncope side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: NA and used Antineoplastic Agents (dosage: Unk) starting
Jan 01, 2011. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Syncope, Dysstasia, DizzinessAdditional drugs used concurrently:
  • Aranesp (300 Mug, Q3wk)
Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Syncope, may still occur.
Antineoplastic Side Effect Report#8255911-6
Confusional State, Muscular Weakness, Coordination Abnormal, Dyspnoea
This Confusional State problem was reported by a physician from United Kingdom. A 68-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On
Jan 27, 2012 this consumer started treatment with Antineoplastic Agents (dosage: NA). The following drugs were being taken at the same time: NA. When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: Confusional State, Muscular Weakness, Coordination Abnormal, DyspnoeaThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Confusional State, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8255908-6
Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase Increased
This Decreased Appetite side effect was reported by a consumer or non-health professional from Germany. A 55-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Antineoplastic Agents (drug dosage: NA), which was initiated on
Jan 25, 2012. Concurrently used drugs:
  • Xgeva (120 Mg, Q4wk)
  • Ibuprofen (600 Mg, Tid)
.After starting to take Antineoplastic Agents the consumer reported adverse symptoms, such as: Decreased Appetite, Neoplasm Progression, Weight Decreased, Blood Alkaline Phosphatase IncreasedThese side effects may potentially be related to Antineoplastic Agents.
Antineoplastic Side Effect Report#8242751-7
Muscular Weakness, Confusional State, Dyspnoea, Coordination Abnormal, Mycobacterium Tuberculosis Complex Test Positive
This is a report of a 68-year-old female patient (weight: NA) from United Kingdom, suffering from the following health symptoms/conditions: NA, who was treated with Antineoplastic Agents (dosage: NA, start time:
Feb 16, 2012), combined with:
  • Ethambutol Hydrochloride
and developed a serious reaction and side effect(s): Muscular Weakness, Confusional State, Dyspnoea, Coordination Abnormal, Mycobacterium Tuberculosis Complex Test Positive after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in female patients, resulting in Muscular Weakness side effect. The patient was hospitalized.
Antineoplastic Side Effect Report#8236630-9
Coordination Abnormal, Confusional State, Muscular Weakness, Dyspnoea
This report suggests a potential Antineoplastic Agents Coordination Abnormal side effect(s) that can have serious consequences. A 68-year-old female patient (weight: NA) from United Kingdom was diagnosed with the following symptoms/conditions: NA and used Antineoplastic Agents (dosage: NA) starting
Jan 27, 2012. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Coordination Abnormal, Confusional State, Muscular Weakness, DyspnoeaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Coordination Abnormal, may still occur.
Antineoplastic Side Effect Report#8229318-1
Leukocytosis
This Death problem was reported by a health professional from United States. A 80-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: lung neoplasm malignant,neutropenia. On NS this consumer started treatment with Antineoplastic Agents (dosage: NA). The following drugs were being taken at the same time:
  • Neulasta (6 Mg, Per Chemo Regim)
When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: LeukocytosisAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Death, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8203859-5
Psychotic Disorder
This Psychotic Disorder side effect was reported by a pharmacist from Netherlands. A 50-year-old female patient (weight:NA) experienced the following symptoms/conditions: breast cancer,neutropenia.The patient was prescribed Antineoplastic Agents (drug dosage: NA), which was initiated on
Nov 08, 2011. Concurrently used drugs:
  • Neulasta (6 Mg, Unk)
.After starting to take Antineoplastic Agents the consumer reported adverse symptoms, such as: Psychotic DisorderThese side effects may potentially be related to Antineoplastic Agents.
Antineoplastic Side Effect Report#8197978-X
Malaise
This is a report of a 53-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: breast cancer metastatic,metastases to bone, who was treated with Antineoplastic Agents (dosage: Unk, start time: NS), combined with:
  • Xgeva (120 Mg, Unk)
and developed a serious reaction and side effect(s): Malaise after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in female patients, resulting in Malaise side effect.
Antineoplastic Side Effect Report#8191500-X
Dehydration, Nausea, Rash, Hyperhidrosis
This report suggests a potential Antineoplastic Agents Dehydration side effect(s) that can have serious consequences. A 50-year-old female patient (weight: NA) from Netherlands was diagnosed with the following symptoms/conditions: breast cancer and used Antineoplastic Agents (dosage: NA) starting
Jan 19, 2012. After starting Antineoplastic Agents the patient began experiencing various side effects, including: Dehydration, Nausea, Rash, HyperhidrosisAdditional drugs used concurrently:
  • Neulasta (6 Mg, After Chemo)
The patient was hospitalized. Although Antineoplastic Agents demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dehydration, may still occur.
Antineoplastic Side Effect Report#8183255-X
Brain Cancer Metastatic
This Brain Cancer Metastatic problem was reported by a health professional from Guatemala. A 66-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Antineoplastic Agents (dosage: Form: Vial). The following drugs were being taken at the same time:
  • Lantus
When using Antineoplastic Agents, the patient experienced the following unwanted symptoms/side effects: Brain Cancer MetastaticAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Brain Cancer Metastatic, may become evident only after a product is in use by the general population.
Antineoplastic Side Effect Report#8170531-X
Confusional State, Muscular Weakness, Coordination Abnormal, Dyspnoea
This Confusional State side effect was reported by a physician from United Kingdom. A 68-year-old female patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Antineoplastic Agents (drug dosage: NA), which was initiated on
Jan 27, 2012. Concurrently used drugs:
  • Rifampicin
.After starting to take Antineoplastic Agents the consumer reported adverse symptoms, such as: Confusional State, Muscular Weakness, Coordination Abnormal, DyspnoeaThese side effects may potentially be related to Antineoplastic Agents. The patient was hospitalized.
Antineoplastic Side Effect Report#8168174-7
Chills, Hypokalaemia, Tubulointerstitial Nephritis, Depressed Level Of Consciousness, White Blood Cell Count Increased, Blood Cortisol Decreased, Leukocyturia, Hypopituitarism, Renal Impairment
This is a report of a female patient (weight: NA) from Japan, suffering from the following health symptoms/conditions: NA, who was treated with Antineoplastic Agents (dosage: NA, start time:
Dec 01, 2009), combined with:
  • Vitamin D (Unk Ukn, Unk)
  • Ts 1 (60 Mg, Unk)
  • Zometa (4 Mg, Qmo)
  • Vitamin D
  • Spiriva
  • Medroxyprogesterone Acetate (400 Mg, Unk)
and developed a serious reaction and side effect(s): Chills, Hypokalaemia, Tubulointerstitial Nephritis, Depressed Level Of Consciousness, White Blood Cell Count Increased, Blood Cortisol Decreased, Leukocyturia, Hypopituitarism, Renal Impairment after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Antineoplastic Agents treatment in female patients, resulting in Chills side effect.


1 of 3 


The appearance of Antineoplastic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

Ask a Doctor Online
12 Doctors are Online.
A Question is Answered Every 9 Seconds!
Ask a Doctor >

What are common Antineoplastic Side Effects for Women?

Women Side EffectsReports
Dyspnoea 7
Confusional State 5
Coordination Abnormal 5
Muscular Weakness 5
Renal Impairment 4
Death 3
Dehydration 3
Hyponatraemia 3
Mucosal Inflammation 3
Ascites 2

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Antineoplastic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Ask a Doctor Online
    12 Doctors are Online.
    A Question is Answered Every 9 Seconds!
    Ask a Doctor >

    Discuss Antineoplastic Side Effects

    Did You Have a Antineoplastic Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Antineoplastic for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Antineoplastic Safety Alerts, Active Ingredients, Usage Information

    More About Antineoplastic

    Side Effects reported to FDA: 73

    Antineoplastic safety alerts: No

    Reported deaths: 21

    Reported hospitalizations: 32

    Latest Antineoplastic clinical trials

    Antineoplastic Reviews

    No reviews, be a first to report a side effect via side effect reporting form